Abstract
Nine 1-phenyl-1H-pyrazolo[3,4-d]pyrimidine derivatives with different substituents in the 4-position of the phenyl group and benzenesulfonamide moiety were synthesized and evaluated against Plasmodium falciparum. Six compounds exhibited activity in vitro against the chloroquine-resistant clone W2 with IC50 values ranging from 5.13 to 12.22 µM. The most active derivative with substituents R1 = F / R2 = CH3 exhibited an IC50 value of 5.13 µM and an IS value of 62.90, which was higher than that of the control drug sulfadoxine. For this reason, it is possible to conclude that the 1H-pyrazolo[3,4-d]pyrimidine system is promising as a prototype for further studies of antimalarial candidates.
Similar content being viewed by others
References
Anthony MP, Burrows JN, Duparc S, JMoehrle J, Wells TNC (2012) The global pipeline of new medicines for the control and elimination of malaria. Malar J 11:316
Azeredo LFSP, Coutinho JP, Jabor VAP, Feliciano PR, Nonato MC, Kaiser CR, Menezes CMS, Hammes ASO, Caffarena ER, Hoelz LVB, Souza NB, Pereira GAN, Ceravolo IP, Krettli AU, Boechat N (2017) Evaluation of 7-arylaminopyrazolo[1,5-a]pyrimidines as anti-Plasmodium falciparum, antimalarial, and Pf-dihydroorotate dehydrogenase inhibitors. Eur J Med Chem 126:72–83
Barnett DS, Guy RK (2014) Antimalarials in development in 2014. Chem Rev 114:11221–11241
Bernardino AMR, Pinheiro LCS, Rodrigues CR, Loureiro NI, Castro HC, Lanfredi-Rangel A, Sabatini-Lopes J, Borges JC, Carvalho JM, Romeiro GA, Ferreira VF, Frugulhettic ICPP, Vannier-Santos MA (2006) Design, synthesis, SAR, and biological evaluation of new 4-(phenylamino)thieno[2,3-b]pyridine derivatives. Bioorg Med Chem 14:5765–5770
Biamonte MA, Wanner J, Le Roch KG (2013) Recent advances in malaria drug discovery. Bioorg Med Chem Lett 23:2829–2843
Boechat N, Ferreira MLG, Pinheiro LCS, Jesus AML, Leite MMM, Aguiar ACC, Andrade IM, Krettli AU (2014) New compounds hybrids 1H-1,2,3-triazole-quinoline against Plasmodium falciparum. Chem Biol Drug Des 84:325–332
Boechat N, Pinheiro LCS, Silva TS, Aguiar ACC, Carvalho AS, Bastos MM, Costa CCP, Pinheiro S, Pinto AC, Mendonça JS, Dutra KDB, Valverde AL, Santos-Filho OA, Ceravolo IP, Krettli AU (2012) New trifluoromethyl triazolopyrimidines as anti-Plasmodium falciparum agents. Molecules 17:8285–8302
Carvalho RCC, Martins WA, Silva TP, Kaiser CR, Bastos MM, Pinheiro LCS, Krettli AU, Boechat N (2016) New pentasubstituted pyrrole hybrid atorvastatin–quinoline derivatives with antiplasmodial activity. Bioorg Med Chem Lett 26:1881–1884
Denizot F, Lang R (1986) Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability. J Immunol Methods 89:271–277
Kaur K, Jain M, Reddy RP, Jain R (2010) Quinolines and structurally related heterocycles as antimalarials. Eur J Med Chem 45:3245–3264
Lambros C, Vanderberg JP (1979) Synchronization of Plasmodium falciparum erythrocytic stages in culture. J Parasitol 65:418–420
Mushtaque M, Shahjahan (2015) Reemergence of chloroquine (CQ) analogs as multi-targeting antimalarial agents: A review. Eur J Med Chem 90:280–295
Noedl H, Wongsrichanalai C, Miller RS, Myint KSA, Looareesuwan S, Sukthana Y, Wongchotigul V, Kollaritsch H, Wiedermann G, Wernsdorfer WH (2002) Plasmodium falciparum: effect of anti-malarial drugs on the production and secretion characteristics of histidine-rich protein II. Exp Parasitol 102:157–163
Pinheiro LCS, Boechat N, Ferreira MLG, Junior CCS, Jesus AML, Leite MMM, Souza N, Krettli AU (2015) Anti-Plasmodium falciparum activity of quinoline–sulfonamide hybrids. Bioorg Med Chem 23:5979–5984
Santos MS, Bernardino AMR, Pinheiro LCS, Canto-Cavalheiro MM, Leon LL (2012) An efficient synthesis of new 5‐(1‐Aryl‐1H‐pyrazole‐4‐yl)‐1H-tetrazoles from 1‐Aryl‐1H‐pyrazole‐4‐carbonitriles via [3 + 2]Cycloaddition reaction. J Heterocycl Chem 49:1425–1428
Schrader FC, Barho M, Steiner I, Ortmann R, Schlitzer M (2012) The antimalarial pipeline-an update. Int J Med Microbiol 302:165–171
Silva TB, Bernardino AMR, Ferreira MLG, Rogerio KR, Carvalho LJM, Boechat N, Pinheiro LCS (2016) Design, synthesis and anti-P. falciparum activity of pyrazolopyridine–sulfonamide derivatives. Bioorg Med Chem 24:4492–4498
Soliman AM, Sultan AA, El Remaily MAA, Abdel-Ghany H (2012) Synthesis of some novel fused azole derivatives. Synth Comm 42:2748–2762
Teixeira C, Vale N, Pérez B, Gomes A, Gomes JRB, Gomes P (2014) “Recycling” classical drugs for malaria. Chem Rev 114:11164–11220
Tilley L, Straimer J, Gnädig NF, Ralph SA, Fidock DA (2016) Artemisinin action and resistance in Plasmodium falciparum. Trends Parasitol 32:682–696
Trager W, Jensen JB (1976) Human malaria parasites in continuous culture. Science 193:673–675
Vandekerckhove S, D’hooghe M (2015) Quinoline-based antimalarial hybrid compounds. Bioorg Med Chem 23:5098–5119
Varotti FP, Botelho ACC, Andrade AA, Paula RC, Fagundes EMS, Valverde A, Mayer LMU, Mendonca JS, Souza MVN, Boechat N, Krettli AU (2008) Synthesis, antimalarial activity, and intracellular targets of MEFAS, a new hybrid compound derived from mefloquine and artesunate. Antimicrob Agents Chemother 52:3868–3874
Wells TN, Hooft van Huijsduijnen R, Van Voorhis WC (2015) Malaria medicines: a glass half full? Nat Rev Drug Discov 14:424–442
White NJ (2004) Antimalarial drug resistance. J Clin Invest 113:1084–1092
World Health Organization (WHO) (2015) Guidelines for the Treatment Of Malaria 3rd ed, 2015. http://www.who.int/malaria/publications/atoz/9789241549127/en/ Accessed 14 Jan 2018
World Health Organization (WHO) (2017) World Malaria Report 2017. http://www.who.int/malaria/publications/world_malaria_report/en/ Accessed 14 Jan 2018
Acknowledgements
We thank the Coordination of Improvement of Higher Education (CAPES) and the National Council of R&D of Brazil (CNPq) for the fellowships granted to the authors. We also thank the Foundation for Research of the State of Rio de Janeiro (FAPERJ), Technological Development Program on Products for Health (PDTIS), for financial support. LJMC, LCSP and NB are recipients of research productivity fellowships from the CNPq and from FAPERJ (“Cientista do Nosso Estado”).
Author information
Authors and Affiliations
Corresponding authors
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
About this article
Cite this article
Silveira, F.F., Feitosa, L.M., Mafra, J.C.M. et al. Synthesis and anti-Plasmodium falciparum evaluation of novel pyrazolopyrimidine derivatives. Med Chem Res 27, 1876–1884 (2018). https://doi.org/10.1007/s00044-018-2199-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00044-018-2199-4